Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 27 entries
Sorted by: Best Match Show Resources per page
Cyanotic congenital heart disease and atherosclerosis.

Heart (British Cardiac Society)

Tarp JB, Jensen AS, Engstrøm T, Holstein-Rathlou NH, Søndergaard L.
PMID: 28259844
Heart. 2017 Jun;103(12):897-900. doi: 10.1136/heartjnl-2016-311012. Epub 2017 Mar 04.

Improved treatment options in paediatric cardiology and congenital heart surgery have resulted in an ageing population of patients with cyanotic congenital heart disease (CCHD). The risk of acquired heart disease such as atherosclerosis increases with age.Previous studies have speculated...

Cite
Tarp JB, Jensen AS, Engstrøm T, et al. Cyanotic congenital heart disease and atherosclerosis. Heart. 2017;103(12):897-900doi: 10.1136/heartjnl-2016-311012.
Tarp, J. B., Jensen, A. S., Engstrøm, T., Holstein-Rathlou, N. H., & Søndergaard, L. (2017). Cyanotic congenital heart disease and atherosclerosis. Heart (British Cardiac Society), 103(12), 897-900. https://doi.org/10.1136/heartjnl-2016-311012
Tarp, Julie Bjerre, et al. "Cyanotic congenital heart disease and atherosclerosis." Heart (British Cardiac Society) vol. 103,12 (2017): 897-900. doi: https://doi.org/10.1136/heartjnl-2016-311012
Tarp JB, Jensen AS, Engstrøm T, Holstein-Rathlou NH, Søndergaard L. Cyanotic congenital heart disease and atherosclerosis. Heart. 2017 Jun;103(12):897-900. doi: 10.1136/heartjnl-2016-311012. Epub 2017 Mar 04. PMID: 28259844.
Copy Download .nbib Format: NLM
Is Coronary Atherosclerosis One Disease or Many? Setting Realistic Expectations for Precision Medicine.

Circulation

Khera AV, Kathiresan S.
PMID: 28289003
Circulation. 2017 Mar 14;135(11):1005-1007. doi: 10.1161/CIRCULATIONAHA.116.026479.

No abstract available.

Cite
Khera AV, Kathiresan S. Is Coronary Atherosclerosis One Disease or Many? Setting Realistic Expectations for Precision Medicine. Circulation. 2017;135(11):1005-1007doi: 10.1161/CIRCULATIONAHA.116.026479.
Khera, A. V., & Kathiresan, S. (2017). Is Coronary Atherosclerosis One Disease or Many? Setting Realistic Expectations for Precision Medicine. Circulation, 135(11), 1005-1007. https://doi.org/10.1161/CIRCULATIONAHA.116.026479
Khera, Amit V, and Kathiresan, Sekar. "Is Coronary Atherosclerosis One Disease or Many? Setting Realistic Expectations for Precision Medicine." Circulation vol. 135,11 (2017): 1005-1007. doi: https://doi.org/10.1161/CIRCULATIONAHA.116.026479
Khera AV, Kathiresan S. Is Coronary Atherosclerosis One Disease or Many? Setting Realistic Expectations for Precision Medicine. Circulation. 2017 Mar 14;135(11):1005-1007. doi: 10.1161/CIRCULATIONAHA.116.026479. PMID: 28289003; PMCID: PMC5395046.
Copy Download .nbib Format: NLM
[Peripheral arterial disease].

Orvosi hetilap

Mikita J.
PMID: 16711257
Orv Hetil. 2006 Apr 23;147(16):723-30.

The peripheral arterial disease (PAD) accounts for very significant medical issue in the world. Various clinical disorders due to coronary, cerebrovascular, abdominal and obliterative arteriosclerosis of extremities can be classified as the most important medical challenges. This review summarises...

Cite
Mikita J. A perifériás artériás érbetegség. [Peripheral arterial disease]. Orv Hetil. 2006;147(16):723-30
Mikita, J. (2006). A perifériás artériás érbetegség. [Peripheral arterial disease]. Orvosi hetilap, 147(16), 723-30.
Mikita, János. "A perifériás artériás érbetegség." [Peripheral arterial disease]. Orvosi hetilap vol. 147,16 (2006): 723-30.
Mikita J. A perifériás artériás érbetegség. [Peripheral arterial disease]. Orv Hetil. 2006 Apr 23;147(16):723-30. Hungarian. PMID: 16711257.
Copy Download .nbib Format: NLM
Is hyperhomocysteinemia a contributor to atherosclerosis in chronic kidney disease patients?.

Nephron. Clinical practice

Suliman ME, Stenvinkel P, Lindholm B.
PMID: 16103724
Nephron Clin Pract. 2005;101(4):c187-9. doi: 10.1159/000087413. Epub 2005 Aug 09.

No abstract available.

Cite
Suliman ME, Stenvinkel P, Lindholm B. Is hyperhomocysteinemia a contributor to atherosclerosis in chronic kidney disease patients?. Nephron Clin Pract. 2005;101(4):c187-9doi: 10.1159/000087413.
Suliman, M. E., Stenvinkel, P., & Lindholm, B. (2005). Is hyperhomocysteinemia a contributor to atherosclerosis in chronic kidney disease patients?. Nephron. Clinical practice, 101(4), c187-9. https://doi.org/10.1159/000087413
Suliman, Mohammed E, et al. "Is hyperhomocysteinemia a contributor to atherosclerosis in chronic kidney disease patients?." Nephron. Clinical practice vol. 101,4 (2005): c187-9. doi: https://doi.org/10.1159/000087413
Suliman ME, Stenvinkel P, Lindholm B. Is hyperhomocysteinemia a contributor to atherosclerosis in chronic kidney disease patients?. Nephron Clin Pract. 2005;101(4):c187-9. doi: 10.1159/000087413. Epub 2005 Aug 09. PMID: 16103724.
Copy Download .nbib Format: NLM
[Consultation for the prevention of atherosclerotic diseases].

Rinsho byori. The Japanese journal of clinical pathology

Okada M, Matsuto T, Miida T, Takahashi A.
PMID: 16190356
Rinsho Byori. 2005 Aug;53(8):708-11.

We have conducted a population-based, long-term trial with the purpose of investigating risk factors for atherosclerotic diseases in a Japanese population, from 1996 (Niigata Study). Through the trial, we have learned what is going on at the initial phase...

Cite
Okada M, Matsuto T, Miida T, et al. [Consultation for the prevention of atherosclerotic diseases]. Rinsho Byori. 2005;53(8):708-11
Okada, M., Matsuto, T., Miida, T., & Takahashi, A. (2005). [Consultation for the prevention of atherosclerotic diseases]. Rinsho byori. The Japanese journal of clinical pathology, 53(8), 708-11.
Okada, Masahiko, et al. "[Consultation for the prevention of atherosclerotic diseases]." Rinsho byori. The Japanese journal of clinical pathology vol. 53,8 (2005): 708-11.
Okada M, Matsuto T, Miida T, Takahashi A. [Consultation for the prevention of atherosclerotic diseases]. Rinsho Byori. 2005 Aug;53(8):708-11. Japanese. PMID: 16190356.
Copy Download .nbib Format: NLM
Analysis of job strain effects.

Occupational and environmental medicine

Mikkelsen S, Bonde JP, Andersen JH.
PMID: 21715440
Occup Environ Med. 2011 Oct;68(10):786. doi: 10.1136/oemed-2011-100203. Epub 2011 Jun 29.

No abstract available.

Cite
Mikkelsen S, Bonde JP, Andersen JH. Analysis of job strain effects. Occup Environ Med. 2011;68(10):786doi: 10.1136/oemed-2011-100203.
Mikkelsen, S., Bonde, J. P., & Andersen, J. H. (2011). Analysis of job strain effects. Occupational and environmental medicine, 68(10), 786. https://doi.org/10.1136/oemed-2011-100203
Mikkelsen, Sigurd, et al. "Analysis of job strain effects." Occupational and environmental medicine vol. 68,10 (2011): 786. doi: https://doi.org/10.1136/oemed-2011-100203
Mikkelsen S, Bonde JP, Andersen JH. Analysis of job strain effects. Occup Environ Med. 2011 Oct;68(10):786. doi: 10.1136/oemed-2011-100203. Epub 2011 Jun 29. PMID: 21715440.
Copy Download .nbib Format: NLM
Reply: To PMID 22899452.

Arthritis care & research

Atzeni F, Sarzi-Puttini P, Gianturco L, Turiel M.
PMID: 24022893
Arthritis Care Res (Hoboken). 2013 Dec;65(12):2063. doi: 10.1002/acr.22154.

No abstract available.

Cite
Atzeni F, Sarzi-Puttini P, Gianturco L, et al. Reply: To PMID 22899452. Arthritis Care Res (Hoboken). 2013;65(12):2063doi: 10.1002/acr.22154.
Atzeni, F., Sarzi-Puttini, P., Gianturco, L., & Turiel, M. (2013). Reply: To PMID 22899452. Arthritis care & research, 65(12), 2063. https://doi.org/10.1002/acr.22154
Atzeni, Fabiola, et al. "Reply: To PMID 22899452." Arthritis care & research vol. 65,12 (2013): 2063. doi: https://doi.org/10.1002/acr.22154
Atzeni F, Sarzi-Puttini P, Gianturco L, Turiel M. Reply: To PMID 22899452. Arthritis Care Res (Hoboken). 2013 Dec;65(12):2063. doi: 10.1002/acr.22154. PMID: 24022893.
Copy Download .nbib Format: NLM
The clinical burden of type 2 diabetes in patients with acute coronary syndromes: prognosis and implications for short- and long-term management.

Diabetes & vascular disease research

Katz P, Leiter LA, Mellbin L, Rydén L.
PMID: 25187508
Diab Vasc Dis Res. 2014 Nov;11(6):395-409. doi: 10.1177/1479164114546854. Epub 2014 Sep 03.

Type 2 diabetes mellitus (T2DM) is associated with increased morbidity and mortality in patients with acute coronary syndromes (ACS). Cardiometabolic risk factors, including hyperglycaemia, insulin resistance, atherogenic dyslipidaemia, increased visceral fat and inflammation, are associated with increased risk in...

Cite
Katz P, Leiter LA, Mellbin L, et al. The clinical burden of type 2 diabetes in patients with acute coronary syndromes: prognosis and implications for short- and long-term management. Diab Vasc Dis Res. 2014;11(6):395-409doi: 10.1177/1479164114546854.
Katz, P., Leiter, L. A., Mellbin, L., & Rydén, L. (2014). The clinical burden of type 2 diabetes in patients with acute coronary syndromes: prognosis and implications for short- and long-term management. Diabetes & vascular disease research, 11(6), 395-409. https://doi.org/10.1177/1479164114546854
Katz, Pamela, et al. "The clinical burden of type 2 diabetes in patients with acute coronary syndromes: prognosis and implications for short- and long-term management." Diabetes & vascular disease research vol. 11,6 (2014): 395-409. doi: https://doi.org/10.1177/1479164114546854
Katz P, Leiter LA, Mellbin L, Rydén L. The clinical burden of type 2 diabetes in patients with acute coronary syndromes: prognosis and implications for short- and long-term management. Diab Vasc Dis Res. 2014 Nov;11(6):395-409. doi: 10.1177/1479164114546854. Epub 2014 Sep 03. PMID: 25187508.
Copy Download .nbib Format: NLM
[Programs for Continuing Medical Education: B session; 1. Pathogenesis of atherosclerosis and an approach to reduce cardiovascular events].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

Hirata K.
PMID: 27319195
Nihon Naika Gakkai Zasshi. 2016 Mar 10;105(3):471-6. doi: 10.2169/naika.105.471.

No abstract available.

Cite
Hirata K. [Programs for Continuing Medical Education: B session; 1. Pathogenesis of atherosclerosis and an approach to reduce cardiovascular events]. Nihon Naika Gakkai Zasshi. 2016;105(3):471-6doi: 10.2169/naika.105.471.
Hirata, K. (2016). [Programs for Continuing Medical Education: B session; 1. Pathogenesis of atherosclerosis and an approach to reduce cardiovascular events]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 105(3), 471-6. https://doi.org/10.2169/naika.105.471
Hirata, Ken-Ichi. "[Programs for Continuing Medical Education: B session; 1. Pathogenesis of atherosclerosis and an approach to reduce cardiovascular events]." Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine vol. 105,3 (2016): 471-6. doi: https://doi.org/10.2169/naika.105.471
Hirata K. [Programs for Continuing Medical Education: B session; 1. Pathogenesis of atherosclerosis and an approach to reduce cardiovascular events]. Nihon Naika Gakkai Zasshi. 2016 Mar 10;105(3):471-6. doi: 10.2169/naika.105.471. Japanese. PMID: 27319195.
Copy Download .nbib Format: NLM
Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Angiology

Wang P, Xu YY, Lv TT, Guan SY, Li XM, Li XP, Pan HF.
PMID: 30009613
Angiology. 2019 Feb;70(2):141-159. doi: 10.1177/0003319718787366. Epub 2018 Jul 15.

Cardiovascular (CV) risk in type 1 diabetes mellitus (T1DM) is increased. In this study, we evaluated the differences in major markers of CV risk between patients with T1DM and healthy controls by a systematic review and meta-analysis. Literature from...

Cite
Wang P, Xu YY, Lv TT, et al. Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Angiology. 2018;70(2):141-159doi: 10.1177/0003319718787366.
Wang, P., Xu, Y. Y., Lv, T. T., Guan, S. Y., Li, X. M., Li, X. P., & Pan, H. F. (2019). Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Angiology, 70(2), 141-159. https://doi.org/10.1177/0003319718787366
Wang, Peng, et al. "Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis." Angiology vol. 70,2 (2019): 141-159. doi: https://doi.org/10.1177/0003319718787366
Wang P, Xu YY, Lv TT, Guan SY, Li XM, Li XP, Pan HF. Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Angiology. 2019 Feb;70(2):141-159. doi: 10.1177/0003319718787366. Epub 2018 Jul 15. PMID: 30009613.
Copy Download .nbib Format: NLM
Does subclinical atherosclerosis really exist in systemic sclerosis? Comment on the article by Turiel et al.

Arthritis care & research

Vacca A, Montisci R, Garau P, Mathieu A.
PMID: 24022883
Arthritis Care Res (Hoboken). 2013 Dec;65(12):2062-3. doi: 10.1002/acr.22153.

No abstract available.

Cite
Vacca A, Montisci R, Garau P, et al. Does subclinical atherosclerosis really exist in systemic sclerosis? Comment on the article by Turiel et al. Arthritis Care Res (Hoboken). 2013;65(12):2062-3doi: 10.1002/acr.22153.
Vacca, A., Montisci, R., Garau, P., & Mathieu, A. (2013). Does subclinical atherosclerosis really exist in systemic sclerosis? Comment on the article by Turiel et al. Arthritis care & research, 65(12), 2062-3. https://doi.org/10.1002/acr.22153
Vacca, Alessandra, et al. "Does subclinical atherosclerosis really exist in systemic sclerosis? Comment on the article by Turiel et al." Arthritis care & research vol. 65,12 (2013): 2062-3. doi: https://doi.org/10.1002/acr.22153
Vacca A, Montisci R, Garau P, Mathieu A. Does subclinical atherosclerosis really exist in systemic sclerosis? Comment on the article by Turiel et al. Arthritis Care Res (Hoboken). 2013 Dec;65(12):2062-3. doi: 10.1002/acr.22153. PMID: 24022883.
Copy Download .nbib Format: NLM
Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management.

Current opinion in pharmacology

Balla S, Nusair MB, Alpert MA.
PMID: 23291030
Curr Opin Pharmacol. 2013 Apr;13(2):192-9. doi: 10.1016/j.coph.2012.12.001. Epub 2013 Jan 03.

Heart disease is the most common cause of death in patients with chronic kidney disease (CKD), particularly in those receiving dialysis. Atherosclerosic cardiovascular (CV) disease (CVD) accounts for a large number of these deaths. Atherosclerosis is accelerated in patients...

Cite
Balla S, Nusair MB, Alpert MA. Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management. Curr Opin Pharmacol. 2013;13(2):192-9doi: 10.1016/j.coph.2012.12.001.
Balla, S., Nusair, M. B., & Alpert, M. A. (2013). Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management. Current opinion in pharmacology, 13(2), 192-9. https://doi.org/10.1016/j.coph.2012.12.001
Balla, Sudarshan, et al. "Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management." Current opinion in pharmacology vol. 13,2 (2013): 192-9. doi: https://doi.org/10.1016/j.coph.2012.12.001
Balla S, Nusair MB, Alpert MA. Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management. Curr Opin Pharmacol. 2013 Apr;13(2):192-9. doi: 10.1016/j.coph.2012.12.001. Epub 2013 Jan 03. PMID: 23291030.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 27 entries